Bryn Mawr Capital Management LLC reduced its position in shares of The Chemours Company (NYSE:CC – Free Report) by 21.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 20,669 shares of the specialty chemicals company’s stock after selling 5,796 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Chemours were worth $349,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in the company. Appian Way Asset Management LP bought a new position in Chemours during the third quarter valued at $34,151,000. Vision One Management Partners LP purchased a new stake in shares of Chemours in the third quarter worth $28,252,000. Scopia Capital Management LP purchased a new stake in shares of Chemours in the third quarter worth $13,623,000. FMR LLC raised its position in shares of Chemours by 3.5% in the third quarter. FMR LLC now owns 18,142,202 shares of the specialty chemicals company’s stock worth $368,650,000 after buying an additional 618,361 shares in the last quarter. Finally, Peregrine Capital Management LLC purchased a new stake in shares of Chemours in the fourth quarter worth $5,731,000. 76.26% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. The Goldman Sachs Group lowered their price target on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. Barclays lowered their price target on Chemours from $23.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Monday. Truist Financial assumed coverage on Chemours in a research report on Tuesday, January 28th. They set a “buy” rating and a $27.00 price target on the stock. BMO Capital Markets lowered their price target on Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 19th. Finally, Mizuho reduced their price objective on Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, Chemours has an average rating of “Hold” and a consensus price target of $23.11.
Chemours Price Performance
CC stock opened at $15.19 on Friday. The firm has a 50 day moving average price of $17.91 and a 200-day moving average price of $18.84. The Chemours Company has a 52-week low of $14.94 and a 52-week high of $29.21. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of 26.66 and a beta of 1.81. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68.
Chemours (NYSE:CC – Get Free Report) last released its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The firm had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion. Equities research analysts forecast that The Chemours Company will post 2.03 EPS for the current fiscal year.
Chemours Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be issued a $0.25 dividend. The ex-dividend date is Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a yield of 6.58%. Chemours’s payout ratio is currently 175.44%.
About Chemours
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Further Reading
- Five stocks we like better than Chemours
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Expert Stock Trading Psychology Tips
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- How to buy stock: A step-by-step guide for beginners
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.